A common vitamin could help fight one of the deadliest brain cancers
Researchers at the University of Calgary are conducting a clinical trial to see if high doses of vitamin B3 can improve outcomes for glioblastoma patients. The study aims to determine if niacin can help the immune system destroy aggressive brain tumor cells.
Why it matters
Glioblastoma is a highly aggressive cancer with limited treatment options, making new therapeutic research critical for patient survival.
For months, Edward (Ed) Waldner knew something wasn't right. At 55 years old, he felt constantly drained, no matter how much or how little he had done during the day. He wondered whether sleep apnea might be to blame. He also noticed subtle changes in the way he walked, including times when his heels seemed to drag.
The article provides a straightforward report on medical research and a patient's experience.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in